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Abstract—This statement examines the relation of the resting ECG to its technology. Its purpose is to foster understanding of how themodern ECG
is derived and displayed and to establish standards that will improve the accuracy and usefulness of the ECG in practice. Derivation of
representative waveforms and measurements based on global intervals are described. Special emphasis is placed on digital signal acquisition
and computer-based signal processing, which provide automated measurements that lead to computer-generated diagnostic statements. Lead
placement, recording methods, and waveform presentation are reviewed. Throughout the statement, recommendations for ECG standards are
placed in context of the clinical implications of evolving ECG technology. (J Am Coll Cardiol 2007;49:1109–27)
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I n the century since the introduction of the string galva-nometer by Willem Einthoven (1), the electrocardiogram
(ECG) has become the most commonly conducted cardiovas-
cular diagnostic procedure and a fundamental tool of clinical
practice (2,3). It is indispensable for the diagnosis and prompt
initiation of therapy in patients with acute coronary syn-
dromes and is the most accurate means of diagnosing intra-
ventricular conduction disturbances and arrhythmias. Its in-
terpretation may lead to the recognition of electrolyte
abnormalities, particularly of serum potassium and calcium,
and permit the detection of some forms of genetically
mediated electrical or structural cardiac abnormalities. The
ECG is routinely used to monitor patients treated with
antiarrhythmic and other drugs, in the preoperative assess-
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ment of patients undergoing noncardiac surgery, and in
screening individuals in high-risk occupations and, in some
cases, for participation in sports. As a research tool, it is used
in long-term population-based surveillance studies and in
experimental trials of drugs with recognized or potential
cardiac effects.
Indications for use of the ECG were summarized in a joint
American Heart Association (AHA)/American College of Car-
diology report in 1992 (4). Because of its broad applicability, the
accurate recording and precise interpretation of the ECG are
critical. The establishment of and adherence to professionally
developed and endorsed evidence-based standards for all phases
of the ECG procedure is an important step in ensuring the high
level of precision required and expected by clinicians and their
patients (5). However, there has not been a comprehensive
updating of ECG standards and criteria since 1978 (6 –14). Since
1978, there have been many advances in the technology of
electrocardiography; in the understanding of the anatomic,
pathological, electrophysiological, and genetic information un-
derlying ECG findings; and in the clinical correlations of ECG
abnormalities. One of the most important changes in electrocar-
diography is the widespread use of computerized systems for
storage and analysis. Many if not most ECGs in the United
States now are recorded by digital, automated machines
equipped with software that measures ECG intervals and ampli-
tudes, provides a virtually instantaneous interpretation, and often
compares the tracing to those recorded earlier by the same
system. However, different automated systems may have differ-
ent technical specifications that result in significant differences
in the measurement of amplitudes, intervals, and diagnostic
statements (15,16).
For these reasons, the AHA initiated an updating of
guideline statements for standardization and interpretation of
the ECG. The project has been endorsed by the American
College of Cardiology, the Heart Rhythm Society, and the
International Society for Computerized Electrocardiology.
The purposes of this project are as follows: (1) to review the
status of techniques currently used to record and interpret the
ECG and to identify opportunities for modification; (2) to
simplify and unify the various descriptive, diagnostic, and
modifying terminologies currently used in order to create a
common and more easily applied lexicon; and (3) to identify
the weaknesses of the descriptive, interpretative, and com-
parative algorithms and recommend changes that incorporate
the newly recognized factors referred to above.
The chairman (L.S.G.) was selected by the Electrocardiog-
raphy and Arrhythmias Committee of the Council on Clinical
Cardiology of the AHA. He formed an advisory group to
assist in setting goals and to recommend other writing group
members. The committee met on 5 occasions to discuss goals,
identify specific areas that required updating, and review
progress. A smaller working/writing group with a group
leader was chosen for each topic. This is the first of 6 articles
written in response to the AHA mandate. It is followed by a
glossary of descriptive, diagnostic, and comparative state-
ments that attempts to minimize repetitive and noninforma-
tive statements. Additional articles, to be published subse-
quently, will discuss the ECG interpretation of intraventricular
conduction disturbances, abnormalities of ventricular repolariza-
tion, hypertrophy, and ischemia/infarction.
The ECG and Its Technology
The purposes of this statement are (1) to examine the relation
of the resting ECG to its technology, (2) to increase under-
standing of how the modern ECG is derived and recorded,
and (3) to promote standards that will improve the accuracy
and usefulness of the ECG in practice. Special emphasis will
be placed on the digital recording methods and computer-
based signal processing that are used in current electrocar-
diographs to provide automated measurements that lead to
computer-generated diagnostic statements. The writing group
recognizes that technical details of the processing and record-
ing of ECGs may be unfamiliar to clinicians. Accordingly, a
major purpose of this document is to provide clinicians with
insight into the generally missing link between technology
and its consequences for clinical ECG interpretation. The
evolution and application of ECG technology have profound
clinical implications, as exemplified by the demonstration
that measurements made by different automated ECG sys-
tems from reference ECG data can vary enough to alter
diagnostic interpretation (15,17). Sensitivity and specificity
of computer-based diagnostic statements are improving, but
at the same time, it remains evident that physician overread-
ing and confirmation of computer-based ECGs is required
(15,16,18).
Previous Standards and Reviews
A number of recommendations for the standardization of
ECG recording and guidelines for ECG interpretation in the
computer era have appeared during the past several decades.
The most recent comprehensive AHA recommendations for
the standardization of leads and general technical require-
ments of ECG instruments were published in 1975 (5). In
1978, task forces of the American College of Cardiology
produced a collection of reports on optimal electrocardiogra-
phy (7), which addressed standardization of terminology and
interpretation (13), the development of databases (6), the
quality of ECG records (12), computers in diagnostic cardi-
ology (9), the use of ECGs in practice (10), cost-effectiveness
of the ECG (11), and a discussion of future directions (14). In
Europe, international common standards for quantitative
electrocardiography (CSE) evolved from the work of Wil-
lems and colleagues (19 –22). The CSE studies were designed
to reduce the wide variation in wave measurements obtained
by ECG computer programs and to assess and improve the
diagnostic classification of ECG interpretation programs (22).
Given the expanding use of computer-based ECG systems
and evolving technology, recommendations for bandwidth
and digital signal processing standards during automated
electrocardiography were formulated in 1990 by a committee
of the AHA (23). In 1991, recommendations of the 1975 and
1990 AHA documents were incorporated into a summary
document on diagnostic ECG devices that was developed by
the Association for the Advancement of Medical Instrumen-
tation (AAMI) and approved by the American National
Standards Institute (ANSI) (24). This document was reaf-
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firmed by ANSI in 2001. Other statements have addressed
related issues of ECG utilization and physician competence in
interpretation of the ECG (16,18,25–27).
The ECG Signal and Its Processing
Automated analysis of the digital 12-lead ECG involves
signal analysis and diagnostic classification (28). Processing
of the ECG occurs in a series of steps, each of which requires
adherence to methodological standards. These steps include
(1) signal acquisition, including filtering; (2) data transfor-
mation, or preparation of data for further processing, includ-
ing finding the complexes, classification of the complexes
into “dominant” and “nondominant” (ectopic) types, and
formation of an average or median complex for each lead; (3)
waveform recognition, which is the process for identification
of the onset and offset of the diagnostic waves; (4) feature
extraction, which is the measurement of amplitudes and
intervals; and (5) diagnostic classification. Diagnostic classi-
fication may be heuristic (ie, deterministic, or based on
experience-based rules) or statistical in approach (29).
The ECG Signal
The standard 12-lead ECG records potential differences
between prescribed sites on the body surface that vary during
the cardiac cycle; it reflects differences in transmembrane
voltages in myocardial cells that occur during depolarization
and repolarization within each cycle. The ECG was regarded
by Einthoven et al (30) as originating in a stationary,
time-dependent single-dipole source that can be represented
by a vector, the heart vector. In this model, voltage in any
lead was explained by projection of the heart vector onto the
straight line that defined the lead axis. Burger et al (31,32)
expanded this concept by treating the lead axes as vectors. A
lead vector, in addition to having a direction that is not the
same as that of the lead axis, also has a length. Voltage in a
lead is not merely the projection of the heart vector on the
lead axis but also its projection on the lead vector times the
length (ie, the “strength”) of the lead vector. Direction and
strength of a lead vector depend on the geometry of the body
and on the varying electric impedances of the tissues in the
torso (31,32). Pairs of electrodes (or a combination of
electrodes serving as 1 of the 2 electrodes) and the tracings
that result from their use are known as leads. Placement of
electrodes on the torso is distinct from direct placement on
the heart, because the localized signal strength that occurs
with direct electrode contact is markedly attenuated and
altered by torso inhomogeneities that include thoracic tissue
boundaries and variations in impedance. At any point in time,
the electrical activity of the heart is composed of differently
directed forces. Accordingly, the potential at any point on the
body surface represents the instantaneous uncanceled electri-
cal forces of the heart, where cancellation also is dependent
on torso inhomogeneities. For further reading, see the com-
prehensive analysis of lead theory by Horacek in 1989 (33).
As electrodes move farther away from the heart, signal
strength decreases together with lead strength. According to
solid angle theory, signal magnitude can be related to both
spatial and nonspatial factors (34). Nonspatial factors include
the magnitude of transmembrane potential difference across a
boundary within the heart. Spatial factors include the proj-
ected boundary of the difference in potential relative to the
area of a sphere of unit size; this will increase with the
absolute size of the area but decrease with distance of the
electrode from the heart. Simultaneously active wave fronts
within the heart may confound the seeming simplicity of
these models.
The fundamental frequency for the QRS complex at the
body surface is 10 Hz, and most of the diagnostic informa-
tion is contained below 100 Hz in adults, although low-
amplitude, high-frequency components as high as 500 Hz
have been detected and studied. The QRS of infants often
contains important components as high as 250 Hz (35). The
fundamental frequency of T waves is approximately 1 to 2 Hz
(23). Filtering of the ECG signal to within the band between
1 to 30 Hz produces a stable ECG that is generally free of
artifact, but this bandwidth is unacceptable for diagnostic
recording because it produces distortions of both high- and
low-frequency components of the signal. The high-frequency
components of the ECG signal define the most rapidly
changing parts of the signal, including Q waves and notched
components within the QRS complex. Because QRS ampli-
tude measurement depends on accurate detection of the peak
of an R wave, an inadequate high-frequency response results
in systematic underestimation of signal amplitude and in
smoothing of notches and Q waves. On the other hand, an
inadequate low-frequency response can result in important
distortions of repolarization. Accordingly, the transfer func-
tions of the filtering algorithms of analog and digital electro-
cardiographs have a major effect on the resulting ECG.
ECG Signal Processing
Processing of the ECG signal by a digital electrocardiograph
involves initial sampling of the signal from electrodes on the
body surface. Next, the digital ECG must eliminate or
suppress low-frequency noise that results from baseline
wander, movement, and respiration and higher-frequency
noise that results from muscle artifact and power-line or
radiated electromagnetic interference (36). As a result, the
ECG signal at the body surface must be filtered and amplified
by the electrocardiograph. Digital filters can be designed to
have linear phase characteristics, and this avoids some of the
distortion introduced by classic analog filters. Once filtered,
individual templates are constructed for each lead from data
sampled generally from dominant complexes, from which
amplitude and duration measurements are made. Global
measurements are made from individual lead data or from
mathematical combinations of simultaneously acquired indi-
vidual lead data. Measurement error has an important effect
on the accuracy of ECG diagnostic statements (37). Refer-
ence is made to the comprehensive analysis of technical
factors that affect the ECG by Zywietz (38). In the present
statement, factors that affect the processing of the ECG signal
will be discussed in terms of technology, clinical implica-
tions, and recommendations.
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Sampling of the ECG Signal
Technology
Direct-writing electrocardiographs, which were preponderant
until the 1970s, recorded signals that were analog, that is,
continuous, in nature. Nearly all current-generation ECG
machines convert the analog ECG signal to digital form
before further processing. Analog-to-digital conversion in
modern digital ECGs generally occurs at the front end, such
as the lead cable module. The initial sampling rate during
analog-to-digital conversion at the front end is higher than the
sampling rate that is used for further processing of the ECG
signal. Oversampling was originally introduced to detect and
represent pacemaker stimulus outputs, which are generally
0.5 ms in duration. Front-end sampling has been performed
at rates from 1000 to 2000 per second, but newer converters
can routinely sample at 10 000 to 15 000 per second or even
higher; other converters are adaptive in sampling rate, with
output that is proportional to the energy detected.
Clinical Implications
The initial sampling rate used by the computer to transform
the analog electrical signal to a series of discrete digital points
(generally described in the unit of samples per second, or
imprecisely as a sampling rate of x Hz) is most often many
times greater than required for further processing of the ECG
signal. This is known as “oversampling.” Pacemaker stimulus
outputs are generally shorter in duration than 0.5 ms, and
therefore, they cannot be reliably detected by ordinary signal
processing technique at 500 to 1000 Hz. Accordingly, a
primary benefit of oversampling is the detection of narrow
pacemaker pulses. Pacemaker detection is not reliably or
accurately performed in all current systems. Oversampling
can also improve signal quality at the high-frequency cutoff.
Separate from difficulties caused by pacemaker spike dura-
tion, the very small amplitudes of modern bipolar pacemaker
stimulus outputs are often too small to be recognized on the
standard ECG, a problem that requires resolution without
introducing artificially enhanced pacemaker signals into the
tracing.
Recommendations
Oversampling by a significant multiple of the upper-
frequency cutoff is recommended to provide recommended
bandwidth in the digitized signal. Manufacturers should
continue to develop improved algorithms for the identifica-
tion and quantitative presentation of pacemaker stimulus
outputs and for their preservation during ECG storage and
retrieval. Low-amplitude pacemaker stimulus outputs should
not be artificially increased in amplitude to aid recognition,
because this would distort the form of the recorded ECG.
Instead, it is recommended that manufacturers incorporate a
separate representation of detected pacemaker stimulus out-
puts into 1 row only of the standard output tracing that would
aid the identification of atrial, ventricular, and biventricular
pacing signals. The selected row might be a rhythm strip that
accompanies the standard 3 rows of lead signals in 4 columns,
or in the absence of a rhythm row, 1 of the standard rows
might be selected for this purpose.
Low-Frequency Filtering
Technology
The heart rate, in beats (cycles) per minute (bpm), when
divided by 60 (seconds per minute) forms a lower bound for
the frequency content in Hertz (Hz, cycles per second). In
practice, this is unlikely to be lower than 0.5 Hz, which
corresponds to a heart rate of 30 bpm; heart rates below 40
bpm (0.67 Hz) are uncommon in practice (23). However, with
traditional analog filtering, a 0.5-Hz low-frequency cutoff
introduces considerable distortion into the ECG, particularly
with respect to the level of the ST segment (39,40). This
distortion results from phase nonlinearities that occur in areas
of the ECG signal where frequency content and wave
amplitude change abruptly, as occurs where the end of the
QRS complex meets the ST segment. Digital filtering pro-
vides methods for increasing the low-frequency cutoff with-
out the introduction of phase distortion (23). This can be
accomplished with a bidirectional filter by a second filtering
pass that is applied in reverse time (41), that is, from the end
of the T wave to the onset of the P wave. This approach can
be applied to ECG signals that are stored in computer
memory, but it is not possible to achieve continuous real-time
monitoring without a time lag. Alternatively, a zero phase
shift can be achieved with a flat step response filter (42),
which allows the reduction of baseline drift without low-
frequency distortion.
Clinical Implications
Low-frequency noise, such as that produced by respiration,
causes the tracing to wander above and below the baseline. A
low-frequency cutoff at 0.5 Hz, which was once widely used
in ECG rhythm monitors, reduces baseline drift due to the
generally lower frequency of respiratory motion but can
result in marked distortion of repolarization that may produce
artifactual ST-segment deviation (39). The 1975 AHA rec-
ommendations included a 0.05-Hz low-frequency cutoff for
diagnostic electrocardiography (5). This recommendation
preserves the fidelity of repolarization, but it does not
eliminate the problem of baseline drift. Baseline drift sup-
pression is necessary for coherent alignment of the sequential
complexes that many modern ECG systems use in the
formation of a representative PQRST complex, which is
sometimes called a template; otherwise, baseline wander can
distort template amplitudes. Newer digital filters can correct
baseline drift while preserving the fidelity of ST-segment
levels, and these digital methods obligate revision of prior
standards required for analog filters.
Recommendation
To reduce artifactual distortion of the ST segment, the 1990
AHA document recommended that the low-frequency cutoff
be 0.05 Hz for routine filters but that this requirement could
be relaxed to 0.67 Hz or below for linear digital filters with
zero phase distortion (23). The ANSI/AAMI recommenda-
tions of 1991, affirmed in 2001, endorsed these relaxed limits
for low-frequency cutoff for standard 12-lead ECGs, subject
to maximum allowable errors for individual determinants of
overall input signal reproduction (24). These standards con-
tinue to be recommended.
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High-Frequency Filtering
Technology
The digital sampling rate (samples per second) determines the
upper limit of the signal frequency that can be faithfully
represented. According to the Nyquist theorem, digital sam-
pling must be performed at twice the rate of the desired
high-frequency cutoff. Because this theorem is valid only for
an infinite sampling interval, the 1990 AHA report recom-
mended sampling rates at 2 or 3 times the theoretical
minimum (23). A series of studies have now indicated that
data at 500 samples per second are needed to allow the
150-Hz high-frequency digital filter cutoff that is required to
reduce amplitude error measurements to 1% in adults
(43,44). Greater bandwidth may be required for accurate
determination of amplitudes in infants (35,45,46). The Euro-
pean CSE group recommended that waveforms should be
recognized if they have amplitudes of at least 20 V and
durations of at least 6 ms (23). This implies a high-frequency
response in the range of 150 Hz. A 2001 Dutch report showed
that in order to keep amplitude errors 25 V in 95% of
the cases, a bandwidth up to 250 Hz is needed for pediatric
cases and up to 150 Hz for adolescents (35).
Clinical Implications
The higher the frequencies contained in the filtered signal, the
more accurate will be the measurement of rapid upstroke
velocity, peak amplitude, and waves of small duration (44).
Inadequate high-frequency response reduces the amplitude of
QRS measurements and the ability to detect small deflections.
Because digital ECGs have a temporal resolution in millisec-
onds and an amplitude resolution in microvolts, recommen-
dations for the high-frequency response of ECGs have
evolved over the years. A high-frequency cutoff of 100 Hz
was considered adequate by the AHA in 1975 to maintain
diagnostic accuracy during visual inspection of direct-writing
tracings by electrocardiographers (5). Even so, it has long
been recognized that higher-frequency components of the
QRS complex are present (47,48) and that these components
may have clinical significance in patients with various forms
of heart disease (49 –51). To measure routine durations and
amplitudes accurately in adults, adolescents, and children, an
upper-frequency cutoff of at least 150 Hz is required; an
upper-frequency cutoff of 250 Hz is more appropriate for
infants. An obvious consequence of these high-frequency
recommendations is that reduction of noise by setting the
high-frequency cutoff of a standard or monitoring ECG to 40
Hz will invalidate any amplitude measurements used for
diagnostic classification (52).
Recommendations
The ANSI/AAMI standard of 1991, reaffirmed in 2001,
recommended a high-frequency cutoff of at least 150 Hz for
all standard 12-lead ECGs (24). The ANSI/AAMI document
also details maximum allowable errors for individual deter-
minants of overall input signal reproduction, which extend
beyond the scope of the present report but are important
guidelines for manufacturers (24). These most recent limits
continue to be recommended for adolescents and for adults,
with extension of the high-frequency cutoff to 250 Hz in
children (35), subject to demonstration of fidelity testing by
individual manufacturers according to standard methods (23).
Electrocardiographs should automatically alert the user when
a suboptimal high-frequency cutoff, such as 40 Hz, is used,
and a proper high-frequency cutoff should automatically be
restored between routine standard ECG recordings.
Formation of a Representative Single-Lead Complex
Technology
QRS waveform amplitudes and durations are subject to
intrinsic beat-to-beat variability and to respiratory variability
between beats. Accordingly, the ANSI/AAMI standards rec-
ommend using the largest-amplitude deflection in each lead
as representative of the magnitude for that measurement (24).
Measurements from digitized records are more reproducible
than those from analog tracings (53). Digital electrocardio-
graphs can reduce or eliminate unwanted beat-to-beat varia-
tions within leads by forming “templates” for individual leads
that serve as representative complexes. Willems et al (54)
have shown that programs that analyzed an averaged beat
showed significantly less variability than programs that mea-
sured every complex or a selected beat; similar findings have
been reported by Zywietz and colleagues (55). Single-lead
average or median-complex templates may be derived from
selected, accurately aligned complexes. One algorithm com-
bines techniques to use the median values of several averaged
cycles. Methods vary for the accurate alignment of normal
PQRST complexes for these purposes but generally involve
template matching and cross-correlation algorithms that ex-
clude nondominant waveforms. Alignment is critical to the
success of the measurement process that follows template
formation. Noise, measured as RMS (root mean square)
residual error in aligned representative complexes, can affect
measurements of duration and compromise the tradeoff be-
tween sensitivity and specificity for infarction criteria, among
other diagnoses (56). Residual error is reduced by incorpo-
ration of more complexes into the representative complex.
Zywietz (43) has demonstrated that noise levels in con-
structed complexes can be reduced to below 5 V to allow
deflections of 20 V to be estimated with no more than 10%
error. However, not all variability between complexes is due
to noise, and a study using the CSE database has suggested
that the diagnostic value of a representative complex may be
improved under some circumstances by consideration of the
classification of individual complexes (57). Although fidelity
standards for other ECG features are contained in the 1990
AHA document (23), no fidelity standard exists for accuracy
of representative beat construction.
Clinical Implications
Some biological beat-to-beat variation undoubtedly exists in
the electrical activity of the heart, separate from respiratory
variability, which is recorded in the surface ECG. For special
purposes, such as the detection of QRS and T-wave alternans,
it may be desirable to retain the ability to examine these
beat-to-beat changes. For routine recording of the ECG,
however, reduction of noise by formation of a single and
stable representative complex for analysis of each lead results
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from exclusion of cycle-to-cycle change. Digital electrocar-
diographs can adjust for respiratory variability and decrease
beat-to-beat noise to improve the measurement precision in
individual leads by forming a representative complex for each
lead. Automated measurements are made from these repre-
sentative templates, not from measurement of individual
complexes. Average complex templates are formed from the
average amplitude of each digital sampling point for selected
complexes. Median complex templates are formed from the
median amplitude at each digital sampling point. As a result,
measurement accuracy is strongly dependent on the fidelity
with which representative templates are formed.
Recommendations
Digital electrocardiographs must provide beat alignment that
allows selective averaging or formation of a representative
complex with fidelity adequate for diagnostic ECG computer
programs. Fidelity standards for construction of representa-
tive complexes need to be developed.
Global Measurement From
Simultaneously Acquired Leads
Technology
Some, but not all, digital electrocardiographs utilize the time
coherence of simultaneously acquired representative com-
plexes to derive “global” measurements of intervals. Tempo-
ral superposition of complexes permits the earliest onset and
latest offset of waveforms to be identified for measurement of
intervals that are more accurate than can be obtained from
single leads. This can be done by searching for the earliest
and latest time points of rapid voltage change across tempo-
rally aligned individual complexes. Alternatively, a spatial
vector magnitude may be created for multiple leads, as
exemplified for 3 leads by (x2y2z2)1/2, and fiducial points
may be determined from this magnitude function. An equally
useful function can be derived as |x||y||z|, where x is
the amplitude difference between 2 consecutive samples in
lead x, etc, which is a spatial velocity function. When only
several selected representative complexes are included in the
global measurement, intervals may still be underestimated if
earliest onset and latest offset times are not detected. Con-
versely, global measurements may overstate intervals by
inclusion of single-lead information that would not be visu-
ally accepted by a human overreader. Differences in mea-
surements may also result from differences in the method of
lead alignment or template formation and from differences in
definition of waveform onset and offset by different algo-
rithms of different manufacturers. The importance of this
phenomenon is seen in determination of the QT interval,
where different approaches to definition of T-wave offset can
confound reproducibility (58,59). It is in this context that
differences in ECG measurement performance of different
computer-assisted analysis programs must be placed (15,17).
Clinical Implications
The capability for simultaneous 12-lead data acquisition by
modern digital electrocardiographs obligates major reconsid-
eration of measurement standards and reference values for
intervals that were originally derived from analog, single-
channel recordings. When the vector orientation of any lead is
approximately perpendicular to the heart vector during the
initial or terminal portion of an ECG waveform, an isoelectric
component of the initial or terminal component of the
waveform will be recorded in that lead at that time. Because
there can be no accurate time alignment of leads in single-
channel recordings, duration measurements from individual
leads will in most cases fail to detect the earliest onset or the
latest offset of waveforms. As a result, measurements from
single leads will systematically underestimate durations of
components of the PQRST complex (21). Simple demonstra-
tion of this phenomenon is seen in the measurement of QT
dispersion that results from isoelectric components of the T
wave in some leads of the normal ECG (60,61).
Measurement from simultaneous leads provides a method
for identification of the earliest onset and latest offset of
waves that are used for duration measurements. Waveform
measurements taken from temporally aligned lead informa-
tion will be systematically greater than the corresponding
measurements made from single leads or measurements
averaged from several leads. P-wave and PR-interval dura-
tions, QRS duration, and QT interval in population studies
will be greater when measured from temporally aligned
multiple leads or from a spatial vector lead template than
when measured from individual leads. In addition, global
measurement can affect Q-wave durations that determine the
ECG diagnosis of myocardial infarction. Accordingly, redef-
inition is required of population-based criteria for first-degree
atrioventricular block, P-wave duration, Q-wave duration in
infarction (relative to the earliest onset of the QRS complex),
QRS duration, and QT intervals measured from simultaneous
lead technology. Several studies of normal limits of ECG
measurements derived from simultaneously recorded 12-lead
ECGs have already been published (62– 66). Global measure-
ment of the QT interval is desirable for routine electrocardi-
ography, but global QT measurement remains problematic
even when derived from temporally aligned complexes. This
is due in part to differences in the currently available
algorithms that are used to define and to identify the end of
the T wave, which can affect measurements (59). Until
reproducible methodology is established in this area, compar-
ative analyses of ECGs must recognize the potential effect of
different algorithms on resulting simultaneous lead measure-
ments. Special situations, such as QT monitoring in drug
trials, may continue to require alternative methods of QT
measurement from single or multiple leads.
Recommendations
Global measurements of intervals should be obtained from
time-coherent data in multiple leads to detect the earliest
onset and latest offset of waveforms. For routine purposes,
global measurements of P-wave duration, PR interval, QRS
duration, and QT duration should be stated on the ECG
report. A comparative study is needed of global measure-
ments made by different methods from a reference standard.
Differences in global measurement algorithms and methods
should be minimized to promote standardization, but these
differences must be accounted for in comparative studies
within individuals and between individuals. Attention must
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be paid to definition of normal ECG ranges in children and
adolescents, as well as in adults, with stratification for
specific age groups, sex, and race. Where methods vary,
algorithm-specific normal ranges for intervals need to be
derived. With respect to QT interval, the end of the T wave as
determined globally should match with a well-defined
T-wave offset in at least 1 of its component individual leads.
Alternative methods of QT measurement from single or
multiple leads may be prescribed for special purposes such as
drug evaluation, but it is inappropriate for studies involving
serial comparison of the QT interval to use differing methods
of QT measurement within trials.
Data Compression for Transmission,
Storage, and Retrieval of ECGs
Technology
Digitized at 500 samples per second, 10 seconds of a single
lead of ECG record requires 10 kB of memory. Accord-
ingly, 10 seconds of an uncompressed 12-lead ECG digitized
at recommended standards would occupy about 80 to 100 Kb
of memory, in addition to memory needed for template
complexes and demographic data. Several methods of ECG
data compression have been used to reduce processing time
and to minimize the memory required for permanent data
storage (67,68). Techniques include fast Fourier, discrete
cosine, and wavelet transforms, as well as hybrid compres-
sion methods (69 –73). These methods can provide compres-
sion ratios of 8:1 to 10:1 with resulting root mean square
errors that range from 0.5% to 2% (69,70,74). Compres-
sion ratio is generally inversely related to root mean square
error, so that a recent algorithm was able to provide a 20:1
compression ratio but with a root mean square error of 4%
(70). Because compression affects high-frequency compo-
nents of the ECG to a greater extent than low-frequency
components, at least 1 algorithm has used bimodal decima-
tion of the signal in which QRS complexes are kept at 500
samples per second while the rest of the recording is
compressed to lower sampling rates (75). Compression of
data may occur before or after signal processing, but in either
case, compression occurs before transfer of the signal to
central storage systems and affects all retrieved records.
Accordingly, the 1990 AHA report recommended that the
fidelity of retrieved compressed data should be within 10 V
for corresponding samples (23). As computer networks in-
crease transmission speed and storage capacity, lossless
compression techniques may supersede other compression
methods for some applications.
Clinical Implications
Compression of ECG data can speed transmission and re-
trieval of records that are stored in central databases and
minimize memory required for storage. Algorithms based on
a variety of mathematical transforms can compress data by a
factor of8, with signal fidelity preserved within about a 2%
overall error. However, the error may not be uniform
throughout the ECG cycle. Data compression affects high-
frequency (short duration) signals more than the smoother
low-frequency signal. Therefore, compression has greater
potential to alter measurements within the QRS complex,
such as pacemaker spikes, Q-wave duration, and R-wave
amplitude, than to alter other signals such as the ST segment
and the T wave. In some cases, a noncompressed ECG taken
at the bedside may differ from the tracing later retrieved from
the stored, compressed file, which may also affect serial
comparison of original and retrieved tracings when ECG
waveforms are reanalyzed (76). Furthermore, differences in
compression methodology may affect comparison of re-
trieved tracings from different manufacturers in the same way
that different filters and different use of time-coherent tem-
plates affect measurements of the ECG signal. These differ-
ences will be minimal when compressed tracings adhere to
established or newer standards of fidelity to the original
signal (23,73), and they can be eliminated with newer
methods of lossless compression (in which no loss of ECG
data occurs).
Recommendation
Compression algorithms should perform in a manner that
allows retrieved data to adhere to the fidelity standards
established in the 1990 AHA statement with reference to the
original signal.
Standard Leads
Location of Standard Limb and Precordial Electrodes
Technology
The standard 12-lead ECG (5,24) consists of 3 limb leads
(leads I, II, and III), 3 augmented limb leads in which the
Goldberger modification of the central terminal of Wilson
serves as a derived indifferent electrode that is paired with the
exploring electrode (leads aVR, aVL, and aVF), and 6
precordial leads in which the Wilson central terminal serves
as a derived indifferent electrode that is paired with the
exploring electrode (V1 through V6). All leads are effectively
“bipolar,” and the term “unipolar” in description of the
augmented limb leads and the precordial leads lacks preci-
sion. Reference is made to the comprehensive study of lead
systems for various types of electrocardiography by Macfar-
lane (77). Skin preparation by cleaning and gentle abrasion
before electrode application can reduce noise and improve the
quality of the recorded ECG (78 – 80). Historically, limb lead
electrodes have been attached at the wrists and the ankles,
with the patient in the supine position, generally with a pillow
under the head. For routine 12-lead recording, the AHA
statement of 1975 recommended placement of the 4 limb lead
electrodes on the arms and legs distal to the shoulders and
hips (5,81), and thus not necessarily on the wrists and ankles.
Evidence exists that different placement of electrodes on the
limbs can alter the ECG, a phenomenon that appears to be
more marked with respect to the left arm electrode (81).
Therefore, reevaluation of the magnitude of changes due to
variation in limb electrode placement in clinical practice is
required, as discussed below. Six electrodes are placed on the
chest in the following locations: V1, fourth intercostal space at
the right sternal border; V2, fourth intercostal space at the left
sternal border; V3, midway between V2 and V4; V4, fifth
intercostal space in the midclavicular line; V5, in the horizon-
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tal plane of V4 at the anterior axillary line, or if the anterior
axillary line is ambiguous, midway between V4 and V6; and
V6, in the horizontal plane of V4 at the midaxillary line.
Clinical Implications
Skin preparation and electrode placement have important
effects on the ECG, and patient positional change, such as
elevation and rotation, can change recorded amplitudes and
axes. It has been widely accepted for many years that ECG
amplitudes, durations, and axes are independent of the distal
or more proximal location of the limb electrodes. As a result,
routine recording of the ECG from the upper arm rather than
from the wrist to “reduce motion artifact” has become
popular and is facilitated by the development of disposable
tab electrodes. However, one study has shown that electrode
placement along the limbs can affect ECG voltages and
durations, most importantly in the limb leads (81). Whether
these differences are large enough to alter routine diagnostic
criteria, such as voltage for left ventricular hypertrophy or
Q-wave duration for inferior infarction, is unknown. Further
confounding this situation is the variability in electrode
placement that might have been present during the actual
derivation of the diagnostic criteria involved, because studies
during the past several decades have rarely described elec-
trode placement in detail.
From the time of their initial standardization by a joint
committee of the AHA and the Cardiac Society of Great
Britain and Ireland (82,83), the normal precordial electrode
positions have been relatively horizontal in orientation. When
precordial electrodes are positioned without reference to the
underlying bony landmarks, the placement pattern often is
erroneously vertical in orientation (84). Mapping data docu-
ment the often profound alterations in waveforms that can
result from precordial electrode misplacement (85,86). A
common error is superior misplacement of V1 and V2 in the
second or third intercostal space. This can result in reduction
of initial R-wave amplitude in these leads, approximating 0.1
mV per interspace, which can cause poor R-wave progression
or erroneous signs of anterior infarction (87). Superior dis-
placement of the V1 and V2 electrodes will often result in rSr
complexes with T-wave inversion, resembling the complex in
lead aVR. It also has been shown that in patients with low
diaphragm position, as in obstructive pulmonary disease
(88,89), V3 and V4 may be located above the ventricular
boundaries and record negative deflections that simulate
anterior infarction. Another common error is inferior place-
ment of V5 and V6, in the sixth intercostal space or even
lower, which can alter amplitudes used in the diagnosis of
ventricular hypertrophy. Precordial lead misplacement ex-
plains a considerable amount of the variability of amplitude
measurements that is found between serial tracings (90).
Some residual disagreement persists in current guidelines and
texts on the standard for location of V5 and V6, with some
sources retaining an early recommendation that these leads
follow the course of the fifth intercostal space rather than the
horizontal plane of V4. In addition, it is common to refer to
the anterior axillary line as an anatomic marker for the
placement of V5. These alternatives are discouraged because
the course of the intercostal space is variable and the
definition of an anterior axillary line only vague. Placement
of precordial electrodes in women with large breasts remains
problematic. Electrodes are most commonly placed beneath
the breast, which should reduce amplitude attenuation caused
by the higher torso impedance in women and, intuitively,
would seem to favor reproducibility of positioning during
routine practice. Conversely, one study has suggested that
reproducibility of ECG measurements is slightly increased
when electrodes are positioned on top of the breast (91).
Another study using precisely ascertained electrode place-
ment has suggested that precordial potential attenuation by
the breast is very small (92). Yet another study has found
attenuation only in V3 and an increase in voltage in V5 and V6
(93) when electrodes are placed over the breast; this may
result from V5 and V6 being correctly placed at the level of V4
rather than more inferiorly when V4 is positioned under the
breast. Clearly, the magnitude of this effect in ordinary ECGs
will depend greatly on the care with which electrodes are
ordinarily placed and also on breast size, breast shape, and
small changes in patient position. Similar considerations
apply in relation to subjects with breast implants and in
subjects who are obese.
Recommendations
Technicians and other medical personnel responsible for the
recording of ECGs should have periodic retraining in skin
preparation, proper electrode positioning, and proper patient
positioning. All leads are effectively “bipolar,” and the
differentiation between “bipolar” and “unipolar” in the de-
scription of the standard limb leads, the augmented limb
leads, and the precordial leads is discouraged. Neither term
should be used. Studies to clarify the effect of distal versus
proximal limb lead electrode placement on ECG magnitudes
and durations are required. Validity of test performance
criteria for current diagnostic algorithms may be dependent
on placement of limb leads in the same positions that were
used for criteria development. Pending resolution of this
issue, all ongoing studies used for criteria development must
clearly document electrode placement with precision. The
horizontal plane through V4 is preferable to the fifth intercos-
tal interspace for the placement of V5 and V6 and should be
used for placement of these electrodes. Definition of V5 as
midway between V4 and V6 is conducive to greater reproduc-
ibility than occurs for the anterior axillary line, and this
should be used when the anterior axillary line is not well
defined. In the placement of V6, attention should be directed
to the definition of the midaxillary line as extending along the
middle, or central plane, of the thorax. For the time being, it
is recommended that electrodes continue to be placed under
the breast in women until additional studies using electrodes
placed on top of the breast are available.
Derivation of the Standard
Limb Leads and Relationships Among Leads
Technology
The 4 limb electrodes define the standard frontal plane limb
leads that were originally defined by Einthoven. With the
right leg electrode acting as an electronic reference that serves
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to improve common mode (unwanted noise) rejection, 3 pairs
of electrodes exist. Within each pair, 1 electrode is estab-
lished as the positive end of the lead in the sense that current
flow toward that electrode is inscribed in an upward (posi-
tive) direction. The other electrode of the pair would inscribe
the exactly opposite waveform. Lead I is defined as the
potential difference between the left arm and the right arm
(LA-RA), lead II is defined as the potential difference
between the left leg and the right arm (LL-RA), and lead III
is defined as the potential difference between the left leg and
the left arm (LL-LA). In each case, net current flow toward
the first electrode of the pair is defined as a positive voltage
deflection in the recorded waveform. According to Kirch-
hoff’s law, the sum of the voltage gains and voltage drops in
a closed circuit is equal to zero. Therefore, lead IIlead
Ilead III at any instant in the cardiac cycle. This relationship
is known as Einthoven’s law.
Clinical Implications
From 3 pairs of limb electrodes, 6 waveforms may be
obtained, 3 of which are defined as the standard limb leads by
establishing 1 of each pair as the electrode toward which net
current flow will inscribe an upward (positive) voltage
deflection on the ECG. The opposite waveforms, by defini-
tion, are mirror images of the standard limb leads. In this
sense, the electrical activity defined by a lead pair can be
examined from either perspective. Distinction of single elec-
trodes from established “poles” is highlighted by selection of
the LA electrode as the positive end of the LA-RA pair for
lead I but not as the positive end of the LL-LA pair for lead
III. Einthoven’s law indicates that any 1 of the standard limb
leads can be mathematically derived from the other 2 leads.
As a consequence, the 3 standard limb leads contain only 2
independent pieces of information. Even though limb lead
placement is often represented in terms of the apices of an
equilateral triangle, known as the Einthoven triangle,
Einthoven’s law is entirely independent of any assumptions
about geometric placement of the 3 electrodes. These consid-
erations notwithstanding, redundant leads promote the appre-
ciation of spatial morphological characteristics of the ECG
and aid in its interpretation, such as calculation of axis, and
consideration of the information from the perspective of both
ends of the available leads can be clinically useful, particu-
larly in the evaluation of ST-segment shifts during acute
myocardial infarction.
Recommendation
Users should recognize the redundancy of information in the
standard limb leads. Redundancy notwithstanding, the infor-
mation contained in different perspectives from multiple
leads can be used to improve recognition of ECG
abnormalities.
Derivation of the Augmented
Limb Leads and the Precordial Leads
Technology
An electrode potential can also be obtained as an average (or
weighted average) of the potentials at 2 or more body surface
locations, which creates a potential that is different from each
of the contributing electrodes alone. Wilson and colleagues
(94) devised a central terminal based on the limb electrodes to
serve as a new reference potential. The Wilson central
terminal (WCT) is obtained as an average potential of the RA,
LA, and LL electrodes, so that the potential at
WCT(RALALL)/3. Kirchhoff’s law does not require
that the potential at WCT be zero or that it remain constant
throughout the cardiac cycle. Potential differences between
WCT and RA, LA, and LL, respectively, defined new frontal
plane limb leads VR, VL, and VF. Wilson called these
electrode pairs the “unipolar” limb leads. Wilson’s VR, VL,
and VF leads had relatively low amplitudes because the
potential at the exploring site was also included in the central
terminal. By removing the single exploring potential from the
central terminal, Goldberger produced the “augmented unipo-
lar” limb leads, so-called because they mathematically are
50% larger in amplitude with respect to recordings that use
the Wilson central terminal (95,96). The Goldberger central
terminals for the augmented limb leads are now obtained as
(LALL)/2 for aVR, (RALL)/2 for aVL, and (RALA)/2
for aVF. Lead aVL therefore represents the potential differ-
ence between the left arm and the modified terminal of
Goldberger and is given by LA(RALL)/2, which can be
reduced to (lead Ilead III)/2. Similarly, lead aVR is
RA(LALL)/2, which can be reduced to (lead Ilead
II)/2, and lead aVF is LL(LARA)/2, which can be
reduced to (lead IIlead III)/2. These derived leads provide
new vectorial perspective within the frontal plane. It should
be noted that aVRaVLaVF0 at any point in the cardiac
cycle. The 6 standard precordial leads are based on potential
differences between an exploring electrode on the chest wall
and the original WCT. Each precordial lead, symbolized as
Vi, represents the potential difference given by ViWCT.
Clinical Implications
The augmented limb leads and the precordial leads use a
derived electrode to serve as the opposing electrode of the
lead pair. Wilson made a reasonable assumption that the
potential oscillations of his central terminal would be small
compared with those of the exploring electrode and that his
“unipolar” leads therefore would largely reflect the potential
variation under the exploring electrode. Later investigators
have often mistakenly taken this to mean that these leads
reflect electrical activity only of cardiac regions in the
vicinity of the exploring electrode. This fails to recognize that
the potential at the exploring electrode is determined by all
cardiac sources electrically active at a given instant of cardiac
excitation and repolarization cycle. Even though the aug-
mented limb leads provide vectorial insight within the frontal
plane, each of these leads can also be mathematically derived
from any 2 of the standard limb leads, as demonstrated above;
accordingly, they do not contain new information but rather
provide new views of cardiac electrical activity. This calcu-
lation is mathematically independent of any assumption about
the equilateral nature of the Einthoven triangle. As a conse-
quence, the 6 frontal plane leads, consisting of the 3 standard
limb leads and the 3 augmented limb leads, actually contain
only 2 independent measured signals. In practice, modern
electrocardiographs measure potential differences for 2 pairs
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of limb lead electrodes and use these measurements to
mathematically derive the third standard limb lead and each
of the augmented limb leads. Although redundancy exists
within the 6 frontal plane leads, visualization of multiple
leads promotes appreciation of spatial aspects of the ECG that
can be important to clinical interpretation. Unlike the math-
ematical relationships between the frontal plane limb leads,
each of the precordial electrodes provides uniquely measured
potential differences at the recording site with reference to the
central terminal. Because the exploring precordial electrodes
are not connected in a closed electrical loop like the extremity
electrodes, the precordial leads are independent of each other;
none can be calculated precisely from other information in
the ECG. Therefore, the “standard” 12-lead ECG actually
contains 8 independent pieces of information: 2 measured
potential differences from which the 4 remaining limb leads
can be calculated and the 6 independent precordial leads.
Recommendations
The augmented limb leads of the frontal plane and the
precordial leads result from derived electrode pairs and
should not be described as “unipolar.” Users should recognize
the derived and redundant nature of the 3 augmented limb
leads, but these are retained because multiple leads facilitate
the clinical interpretation of the ECG.
Simultaneous Lead Presentation
Technology
With analog single-channel ECG recorders, each lead is
recorded sequentially by means of a switching mechanism
that connects applied electrodes in the prescribed combina-
tions. Digital electrocardiographs are able to record the 8
channels of independent information simultaneously, with 4
of the limb leads being derived from the other 2. Alignment
of separate channel writers must be precise to within 10 ms
(24), and ideally less. The most commonly used output
format involves lead separation based on rows and columns.
For standard-sized paper, at 25 mm/s recording speed, four
2.5-second columns can be presented sequentially on the
page, with no time disruption between different columns.
Each column therefore represents successive 2.5-second in-
tervals of a continuous 10-second record. In the most tradi-
tional simultaneous lead format, the first column records rows
representing simultaneous leads I, II, and III; the second
column records rows representing simultaneous aVR, aVL,
and aVF; the third column represents simultaneous leads V1,
V2, and V3; the fourth column represents simultaneous leads
V4, V5, and V6. Additional rows may be available for 1, 2, or
3 leads of 10-second continuous recordings for rhythm
analysis. Alternatively, additional rows may be utilized to
present two 5-second recordings of 6 simultaneous limb leads
and 6 simultaneous precordial leads, or 12 rows of simulta-
neous leads.
Clinical Implications
The major advantage of simultaneous lead acquisition is that
it allows precise temporal alignment of waveforms from
different leads, which results in spatial-temporal insights that
have diagnostic value (97). By way of example, the temporal
alignment of waveforms in aVR and aVL can aid in the
diagnosis of fascicular block in the presence of infarction
(98), whereas simultaneous views of P-wave and QRS
waveforms in multiple leads can add information of value in
the interpretation of arrhythmias and in the diagnosis of
myocardial infarction (99).
Recommendation
Standard tracings obtained with digital electrocardiographs
should provide accurate temporal alignment of multiple leads,
with maximum misalignment of no more than 10 ms, and
ideally as little as is practically feasible. The printed tracing
may present temporally aligned groups of leads in different
formats according to preference.
Alternative Information
Format From Standard Leads
Technology
The Cabrera or orderly sequence reorients the frontal plane
leads into a progressive anatomic array that extends logically
and sequentially in the same way that the precordial leads
progress sequentially from V1 through V6 (100,101). With
inverted aVR (aVR or maVR) used to represent the signal
between leads II and I, the sequence becomes, from right to
left, III, aVF, II,aVR, I, and aVL, or from left to right, aVL,
I, aVR, II, aVF, and III. In addition to improved spatial
quantification of acute infarction, the Cabrera sequence
facilitates calculation of the frontal plane axis (102). This
presentation, when in sequence with the precordial leads, has
also been termed the panoramic display (103).
Clinical Implications
Whether presented serially from single-channel recorders or
in standard array from simultaneous-lead–acquisition de-
vices, the sequence of limb lead presentation on ECG
recordings is historical, not anatomic. Thus, whereas V1
through V6 progress leftward and slightly inferiorly across the
precordium, the frontal plane limb leads follow no regular
order that allows individual leads to be compared easily with
anatomically directly adjacent leads. For example, lead aVF
represents the potential difference from a vector perspective
that is between lead III and lead II, but this is not easily
appreciated from the standard array. Similarly, leads I and
aVL are progressively counterclockwise, in the anatomic
sense, from lead II. Lead aVR is often thought of as an
intracavitary lead that looks toward the atria from the apex of
the ventricles, but inversion of aVR can be considered to
represent a perspective that lies anatomically within the
counterclockwise progression from lead II to lead I (101).
Use of inverted aVR has been reported to improve the
diagnostic classification and estimation of risk associated
with acute inferior and lateral myocardial infarction (104).
Recommendations
Routine use of the Cabrera sequence for display of the limb
leads can be highly recommended as an alternative presenta-
tion standard. For display in a format of 4 columns of 3 leads,
a left-to-right sequence (aVL to III) is logical because it is
closer to traditional placement of limb lead I at the upper left.
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To maintain consistency, the left-to-right sequence is also
recommended for horizontal display of the limb leads. How-
ever, it is recognized that the current limb lead array is so
deeply entrenched in ECG tradition that change might take
years to become generally accepted. At present, manufactur-
ers should be encouraged to make this display available as a
routine option in new electrocardiographs.
Alternative Lead Applications
Torso and Other Modified
Placement of the Limb Leads
Technology
Noise from motion of the arms and legs during ambulatory
and exercise electrocardiography can be reduced by place-
ment of the limb leads on the torso. In these diagnostic
applications, 12-lead ECGs have been recorded with the
Mason-Likar lead position (105), in which the arm electrodes
are placed in the infraclavicular fossae medial to the deltoid
insertions and the left leg electrode is placed midway between
the costal margin and iliac crest in the left anterior axillary
line. More recent applications of the Mason-Likar monitoring
position place the arm electrodes over the outer clavicles
(81,106). The precordial electrodes are placed in the standard
positions. An alternative modification of limb lead placement
developed for bicycle ergometry applies the arm electrodes to
the upper outer arm and the leg electrodes to the anterior iliac
crest (107). Torso limb leads are sometimes used to reduce
motion artifact from the arms and legs during recording in
infants.
Clinical Implications
Noise from motion of the limbs during routine ambulation
and during exercise makes standard limb lead electrode
placement impractical for ECG monitoring. Typical monitor-
ing applications include bedside hard-wired or telemetered
observation of rhythm and ST segments, quantitative ambu-
latory electrocardiography, and ECG recording during diag-
nostic exercise testing (108). Rhythm diagnosis is not ad-
versely affected by monitoring lead placement; however,
tracings that use torso electrodes differ in important ways
from the standard 12-lead ECG. In addition to body position
differences that affect the ECG (109), monitoring electrodes
placed on the trunk do not provide standard limb leads, and
distortion of the central terminal alters the augmented limb
leads and the precordial leads (110,111). Tracings with
Mason-Likar and other alternative lead placement may affect
QRS morphology more than repolarization compared with
the standard ECG; these differences can include false-
negative and false-positive infarction criteria (81,112). Mo-
tion artifact of the limbs is a particular problem for routine
recording in neonates, infants, and young children, in whom
torso leads are sometimes used; the clinical significance of
the resulting differences remains to be established.
Recommendations
ECGs recorded with torso placement of the extremity elec-
trodes cannot be considered equivalent to standard ECGs for
all purposes and should not be used interchangeably with
standard ECGs for serial comparison. Evaluation of the effect
of torso placement of limb leads on waveform amplitudes and
durations in infants is required. Tracings that use torso limb
lead placement must be clearly labeled as such, including
12-lead tracings derived from torso limb lead placement in
neonates or in young children and during ambulatory and
exercise electrocardiography in adults. Furthermore, tracings
recorded in the sitting or upright position should not be
considered equivalent to standard supine ECGs.
Reduced Lead Sets
Technology
It is possible to mathematically construct a synthesized
12-lead ECG from reduced lead sets. These syntheses can
approximate but not duplicate the tracing obtained by the
standard leads. The Frank lead system was devised as a lead
set suitable for obtaining reproducible orthogonal lead infor-
mation that could be used for vectorcardiography (5). The
system involves 7 electrodes, 5 of which are applied at points
in the horizontal plane that intersect the fifth intercostal space
at the left sternal border: A at the left midaxillary line, C on
the anterior left chest wall halfway between E and A, E at the
mid sternum anteriorly, I at the right midaxillary line, and M
at the mid spine posteriorly. In addition, electrode H is placed
at the junction of the neck and torso posteriorly, and electrode
F is placed on the left foot. Orthogonal lead information is
constructed from modeled weighting of lead voltages. The
EASI lead system is a reduced 5-lead set that uses the E, A,
and I electrodes from the Frank lead system and adds an
electrode, S, at the top of the mid sternum, along with a
ground reference electrode to provide orthogonally oriented
signals (113). In addition to orthogonal data, transfer coeffi-
cients have been developed for the EASI lead system that
produce synthesized 12-lead ECGs (114). Advantages of the
EASI lead system for patient monitoring applications are the
absence of limb electrodes, which allows the patient to move
around without intolerable noise in the ECG signal, elimina-
tion of the need to determine intercostal spaces, and avoid-
ance of the breast.
Clinical Implications
Because monitoring applications of reduced lead sets are
widespread and 12-lead reconstruction algorithms are avail-
able in practice, it is important that the derived nature of these
tracings is appreciated. The Frank lead system and other
vectorcardiographic lead systems produce the orthogonal X,
Y, and Z components of the heart vector. These can be
combined into 3-dimensional vectorcardiographic loops dis-
played in 2-dimensional planes (frontal, horizontal, and
sagittal); they can be directly examined as ECG voltage-time
records as well. A number of transformations of orthogonal
data can be used to produce a synthesized 12-lead ECG, but
the generalized transfer coefficients used in these estimations
are subject to individual variability in torso shape and
heterogeneities of impedance. Patient-specific transforma-
tions derived from comparison with a baseline 12-lead ECG
can improve the accuracy of subsequent synthesized tracings.
Torso inhomogeneities also limit the fidelity of synthesized
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12-lead tracings derived from EASI leads. An advantage of
EASI leads is the relative anatomic simplicity of electrode
placement. Tracings synthesized from the EASI leads have
been shown to have useful correlative value with the standard
12-lead ECG (115,116); however, it is recognized that these
synthesized tracings can differ in interval duration and
amplitude from the corresponding standard ECGs. Whether
synthesized 12-lead tracings provide practical advantage and
adequate reproduction of ST-segment shifts to be a substitute
for standard tracings during acute ischemic syndromes is a
matter of intense current investigation (117). Whether the
accuracy of these transformations for the monitoring of
repolarization changes can facilitate drug trials in ambulatory
subjects is also under study.
Recommendations
Synthesized 12-lead ECGs are not equivalent to standard
12-lead ECGs and cannot be recommended as a substitute for
routine use. All 12-lead tracings derived by synthesis from
reduced lead sets must be clearly labeled as such. Although
synthesized ECGs that use the EASI lead system may be
demonstrably adequate for some purposes, such as monitor-
ing of rhythm, they cannot be considered equivalent to
standard 12-lead recordings or recommended at present as an
alternative for routine use.
Expanded Lead Sets
Technology
Hybrid lead systems, incorporating 3 Frank leads with the
standard 12 leads, can be used by some electrocardiographs.
Expanded lead sets include the multiple-electrode arrays used
for body surface mapping of the electrical activity of the
heart. Torso arrays include wraparound electrodes in multiple
horizontal and vertical lines. Details of these arrays are
beyond the scope of the present report. Studies of body
surface maps recorded from large electrode arrays have
provided useful information about localization of ECG infor-
mation on the thorax, but their complexity precludes their use
as a substitute for the standard 12-lead ECG for routine
recording purposes. Additional chest leads may be useful for
investigation of acute infarction. Four additional precordial
leads have been identified for use in this clinical setting (V3R,
V4R, V5R, and V6R), each of which is placed on the right side
in mirror image to the standard precordial placement of
electrodes. Within this right-sided array of electrodes, stan-
dard V1 can be considered equivalent to V2R, and standard V2
can be considered equivalent to V1R. Examination of addi-
tional posterior chest leads has been proposed for the identi-
fication of ST-elevation events in the posterior wall, includ-
ing V7 (at the posterior axillary line), V8 (below the scapula),
and V9 (at the paravertebral border), each in the same
horizontal plane as V6 (118 –120).
Clinical Implications
Although acute right ventricular infarction can sometimes be
recognized from ST-segment elevation in V1, studies dating
from the early 1980s have demonstrated that additional
right-sided precordial leads have value for the diagnosis of
acute right ventricular infarction in patients with inferior
infarction (121–123). In this setting, ST-segment elevation
exceeding 0.1 mV in 1 or more of the right precordial leads
is moderately sensitive and specific for right ventricular
injury and has been associated with underlying right ventric-
ular dysfunction (124,125) and greater in-hospital complica-
tions (126). Acute infarction of the posterior wall of the left
ventricle theoretically can be diagnosed from reciprocal
ST-segment depression evident in precordial leads V1 through
V3, and it appears that both the additional right-sided and
additional posterior leads can be reconstructed from the
standard ECG leads (127). (Alternate description of this
territory as anatomically inferolateral rather than posterior
will be discussed elsewhere.) Additional leads have not
provided increased sensitivity for infarction in all studies
(128); however, ST-segment elevation over the posterior left
chest has been reported to be the only site of ST elevation
found in some cases of posterior infarction (118). Recent
guidelines for intervention in acute coronary syndromes
differ in important ways for ST-elevation and for non–ST-
elevation infarction (129). In this sense, anterior ST depres-
sion during infarction from a spatial vector perspective may
be electrocardiographically equivalent to posterior ST eleva-
tion, but it may be quite different in terms of a literal
interpretation of treatment guidelines that requires “ST ele-
vation” in an intervention algorithm. Even so, ST elevation in
posterior leads in acute posterior infarction is often1 mm in
amplitude, and because of lead orientation, proximity effect,
and torso inhomogeneity, it may not be equivalent in absolute
magnitude to the ST depression present in anterior leads. ST
elevation in 1 or more of the posterior leads has moderate
sensitivity and high specificity for posterior wall infarction
(130), but the value of these additional findings for the
prediction of increased in-hospital complications is unre-
solved (126,131).
Recommendations
Because treatment of infarction may vary with right ventric-
ular involvement, recording of additional right-sided pre-
cordial leads during acute inferior-wall left ventricular infarc-
tion is recommended. Routine recording of these leads in the
absence of acute inferior infarction is not recommended. The
use of additional posterior precordial leads can be recom-
mended in settings in which treatment will depend on
documentation of ST elevation during infarction or other
acute coronary syndrome. Routine recording of these addi-
tional leads in the absence of an acute coronary syndrome is
not recommended. As ST-segment vectors become increas-
ingly used for improved diagnostic classification of myocar-
dial infarction, the addition of a frontal plane ST-segment
axis to the currently measured P-wave, QRS, and T-wave
axes in the ECG header data is recommended.
Lead Switches and Misplacements
Limb Lead and Precordial Lead Switches
Technology
Lead switches (or more correctly, electrode cable switches)
occur when a dedicated lead wire and electrode combination
is misplaced or when there is erroneous attachment of a
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dedicated lead wire to individually placed electrodes. Color
coding of lead wires is a feature of manufacturing standards
for electrocardiographs (24), but even so, it is possible to
misconnect lead wires at the cable terminal. Time-coherent
P-wave morphology can be used to clarify lead switches
(132), and these principles should be applicable to computer
algorithms. Computer algorithms that are adaptable to
computer-assisted electrocardiographs are capable of detect-
ing lead switches (133–137).
Clinical Implications
Lead switches are really switches of the cable connections of
2 or more properly placed electrodes. This can result in
erroneous pairing within the standard limb leads or within the
pairing of an exploring lead with the central terminal. When
an electrode that is switched involves the central terminal, all
leads may be affected. Lead switches affect 2 or more of the
standard leads, thereby distorting the ECG recording. Limb
lead switches can result in false-positive and false-negative
signs of ischemia (138). Some of these changes can be
recognized by an alert technician or correctly interpreted by
the reviewing physician, particularly when previous ECGs
are available, whereas others may go unrecognized or require
repeat recording of the ECG (139). Transposition of the left
and right arm lead wires produces inversion of limb lead I,
with a switch of leads II and III and a switch of leads aVR and
aVL, whereas aVF remains unaltered. Because the central
terminal is unaffected, there are no changes in the precordial
leads. In normal situations, lead I is generally similar to V6
with respect to the morphology of the P wave and QRS
direction. A clue to distinction of these findings from those
present in a patient with mirror-image dextrocardia is that
lead misplacement results in an important discordance be-
tween lead I and V6. As a corollary, the ECG in a patient with
mirror-image dextrocardia may be “normalized” by pur-
posely reversing the left and right arm lead wires and using
mirror-image right-sided precordial leads. Transposition of
the right arm and right leg lead wires is also easy to
recognize, because lead II now records the nearly zero
potential difference that exists between the 2 legs (140,141),
which results in very low amplitude only in lead II, with
inverted symmetry between standard lead I and lead III.
Transposition of the left arm and left leg lead wires is more
difficult to recognize because the main effects are an often
subtle shift in axis and inversion of lead III; it can be
suspected from changes in P-wave morphology in the limb
leads (138), although the specificity of this approach has been
challenged (137). Suspected lead switches may be confirmed
by reference to a prior or subsequent tracing with correct lead
placement. Transposition of lead wires to V1 and V2, to V2
and V3, or within all 3 leads can cause a reversal of R-wave
progression that simulates anteroseptal wall infarction, but
this artifact often can be recognized by distorted progression
of the precordial P waves and T waves in the same leads.
Recommendations
Medical personnel responsible for the recording of routine
ECGs should receive training on the avoidance of lead
switches and guidelines for their recognition. Lead-switch
detection algorithms should be incorporated into digital
electrocardiographs along with alarms for abnormally high
lead impedance, and suspected misplacements should be
identified to the person recording the ECG in time to correct
the problem. If not corrected before recording, a diagnostic
statement alerting the reader to the presence of different types
of lead switches should be incorporated into preliminary
interpretive reports.
Lead Misplacement
Technology
ECG amplitudes and duration measurements vary with pre-
cordial lead placement, which often ranges widely from the
recommended anatomic sites (84,142). The early work of
Kerwin et al (143) demonstrated that reproducibility of
precordial lead placement to within 1 cm occurred only in
about half of men and in even fewer women. Placement
accuracy during routine electrocardiography appears to have
decreased further with time. A recent study documented that
fewer than two thirds of routinely applied precordial elec-
trodes were applied within 1.25 inch of the designated
landmark, but errors were not distributed randomly (84). A
more vertical distribution of precordial electrodes than re-
quired resulted from superior misplacement of V1 and V2
electrodes in more than half of cases and inferior-leftward
misplacement of left precordial electrodes in more than one
third.
Clinical Implications
Lead placement variability between recordings is an impor-
tant reason for poor reproducibility of precordial ECG am-
plitude measurements (86,90,144). Reproducibility of dura-
tion measurements is generally better than reproducibility of
amplitudes (145). It has been established that variation in pre-
cordial lead placement of as little as 2 cm can result in
important diagnostic errors, particularly those that involve
statements about anteroseptal infarction and ventricular hy-
pertrophy (142). Precordial lead misplacement can alter
computer-based diagnostic statements in up to 6% of record-
ings (85).
Recommendations
Periodic retraining in proper lead positioning of the pre-
cordial leads should be routine for all personnel who are
responsible for the recording of ECGs. Serial tracings in acute
or subacute care settings should make use of some form of
skin marking to promote reproducibility of lead placement
when it is not possible to leave properly applied electrodes in
place.
Computerized Interpretation of the ECG
Technology
Two computer-based processes are required for diagnostic
digital ECG programs that provide diagnostic interpretation.
The first stage is preparation of the signal for analysis by the
processing methods discussed above. As discussed in prior
sections of this statement, the fidelity of measurements used
in diagnostic algorithms is determined by the technical issues
1121JACC Vol. 49, No. 10, 2007 Kligfield et al.
March 13, 2007:1109–27 Standardization and Interpretation of the ECG, Part I
that affect signal processing (9,23,28,42,146). These signal-
processing methods include signal preparation (sampling,
filtering, and template formation), feature extraction, and
measurement (147–151). Time-coherent simultaneous lead
data and the construction of representative template com-
plexes are critical to the reliability of feature extraction and
measurement; global measurements of duration may be sys-
tematically smaller when time-coherent data are not used.
The second stage of analysis applies diagnostic algorithms to
the processed ECG. Diagnostic algorithms may be heuristic
(experience-based rules that are deterministic) or statistical
(probabilistic) in structure. Heuristic diagnostic algorithms
were originally designed to incorporate discrete measurement
thresholds into a decision tree or boolean combinations of
criteria (152–155). Statistical diagnostic algorithms circum-
vent problems of diagnostic instability that are associated
with small serial changes around discrete partitions by adding
a probability statement to the diagnosis. These may be based
on bayesian logic (156). Other statistical methods use dis-
criminant function analysis, which can use continuous ECG
parameters in addition to discrete variables to produce a point
score (157,158). These algorithms tend to be more reproduc-
ible than earlier heuristic methods, even though they still may
result in discrete thresholds for diagnostic statements. Neural
nets differ from conventional discriminant function analysis
in the way they are trained, in the resulting classifier, and in
their derived decision boundaries (133,159,160). Statistical
methods depend on a database of well-documented cases to
find the optimal ECG parameters to use. Such a database
must be large enough that the results are statistically reliable.
The database must contain sufficient cases with varying
degrees of abnormality, ranging from mild to severe cases,
and a representative distribution of common confounding
conditions (6,9,17,161). The statistics of well-documented
populations have been used to develop diagnostic algorithms
that no longer simply mimic the human reader (162). Simi-
larly, it has also been shown that the addition of vector loop
criteria (or the equivalent information deduced from simul-
taneous leads) improves 12-lead ECG diagnoses (97,98).
Clinical Implications
Given the potentially profound effects of technical factors on
ECG measurements, it is not surprising that identical diag-
nostic algorithms might perform differently when applied to
ECG signals that undergo processing by different methods.
Adherence to methodological standards will minimize these
differences, promote uniformity of measurement and inter-
pretation, and facilitate serial comparison of tracings. Even
with adherence to standards, small systematic differences in
measurements might be expected between diagnostic instru-
ments that use different processing methods, particularly with
respect to diagnostically important global measures of QRS
duration and QT interval. A 1985 study by the European CSE
group demonstrated that measurement differences among 10
standard ECG systems could be large enough to alter diag-
nostic conclusions (17); however, no recent studies have
directly compared template and global measurements made
with the current generation of commercially available stan-
dard ECG recording systems. Beyond the technical issues of
measurement fidelity, evaluation of the performance of ECG
programs is difficult (9,15,17,163). Programs may be com-
pared with diagnoses of an expert cardiologist or consensus
of expert cardiologists or with diagnoses ascertained by
independent data. The CSE group evaluated 15 ECG and
vectorcardiographic analysis programs against a reference
database that included documented cases of ventricular hy-
pertrophy and myocardial infarction (15), diagnoses that are
strongly dependent on accurate measurement of amplitudes
and durations and should favor computer analysis. Overall,
the percentage of ECGs correctly classified by the computer
programs (median 91.3%) was lower than that for the
cardiologists (median 96.0%), whereas important differences
in overall accuracy were found between different algorithms.
Salerno et al (18) reviewed 13 reports of computer ECG
program performance and showed that these programs gen-
erally perform less well than expert readers with respect to
individual diagnoses. Even so, this report found that com-
puter assistance was able to improve the diagnostic perfor-
mance of less expert readers.
Recommendations
Computer-based interpretation of the ECG is an adjunct to the
electrocardiographer (164), and all computer-based reports re-
quire physician overreading. Accurate individual templates
should be formed in each lead before final feature extraction and
measurement used for diagnostic interpretation. Time-coherent
data from multiple leads should be used to detect the earliest
onset and latest offset of waveforms of global measurements
used for diagnostic interpretation. Deterministic and statistical or
probabilistic algorithms should be based on well-constructed
databases that include varying degrees of pathology and an
appropriate distribution of confounding conditions. Such algo-
rithms should be validated with data that have not been used for
development. Programs using complex diagnostic algorithms
should document in reference material those measurements that
are critical to the diagnostic statement, which might include
synthesized vector loop or other novel measurements. Serial
comparisons of sequential ECGs should be done by trained
observers regardless of whether the ECG program provides a
serial comparison. Assessment of the performance of different
algorithms will be facilitated by use of a standardized glossary of
interpretive statements.
Summary
The present document outlines the relation of the modern
digital electrocardiograph to its technology. Individual fea-
tures of ECG processing and recording are considered in
terms of their clinical implications. Recommendations focus
on progress toward optimal use of the ECG. It is hoped that
the standards set out in this document will provide a further
stimulus to the improvement of ECG recording and
interpretation.
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